Opinion

Video

Panel Discuses Use of CD19 Bispecifics in Sequencing

Bradley Hunter, MD, and Fred Locke, MD, and Elizabeth Budde, MD, PhD, share insights surrounding treatment considerations for CD19 targeting.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Video content above is prompted by the following:

    • Is there a concern about targeting CD19 prior to administering CAR t-cell therapy?

    Newsletter

    Stay up to date on the most recent and practice-changing oncology data

    Related Content